Growth factor delivery-based tissue engineering: general approaches and a review of recent developments.
The identification and production of recombinant morphogens and growth factors that play key roles in tissue regeneration have generated much enthusiasm and numerous clinical trials, but the results of many of these trials have been largely disappointing. Interestingly, the trials that have shown benefit all contain a common denominator, the presence of a material carrier, suggesting strongly that spatio-temporal control over the location and bioactivity of factors after introduction into the body is crucial to achieve tangible therapeutic effect. Sophisticated materials systems that regulate the biological presentation of growth factors represent an attractive new generation of therapeutic agents for the treatment of a wide variety of diseases. This review provides an overview of growth factor delivery in tissue engineering. Certain fundamental issues and design strategies relevant to the material carriers that are being actively pursued to address specific technical objectives are discussed. Recent progress highlights the importance of materials science and engineering in growth factor delivery approaches to regenerative medicine.
Lee
Kangwon
K
School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02139, USA.
Silva
Eduardo A
EA
Mooney
David J
DJ
D001672:Biocompatible Materials / Q000627:therapeutic use*; D016503:Drug Delivery Systems / Q000379:methods*; D005109:Extracellular Matrix / Q000378:metabolism; D048091:Guided Tissue Regeneration / Q000379:methods*; D036341:Intercellular Signaling Peptides and Proteins / Q000008:administration & dosage / Q000378:metabolism*; D053758:Nanoparticles; D020239:Receptor Cross-Talk / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology*; D023822:Tissue Engineering / Q000379:methods*
D001672:Biocompatible Materials; D036341:Intercellular Signaling Peptides and Proteins